Now in its twenty-first year, IHV2019 will convene to address strategies to end the HIV/AIDS epidemic, and the intersection of HIV and opioid use disorder (OUD). The conference will open by highlighting the recent plan for Ending the HIV Epidemic by 2030, with expert opinions from Dr. Carl Diffenbach, Director of Division of AIDS, NIAID, Dr. Anthony Fauci, Director of NIAID, and Dr. Robert Redfield, Director of the CDC and Institute of Human Virology (IHV) Founding Member. A critical component of ending the HIV epidemic is successful implementation of prevention strategies. Sexual education, condoms, syringe exchange, and pre-exposure prophylaxis will be reviewed, along with challenges and possibilities in wide-spread implementation. In addition, various agencies will describe the utilization of broad epidemiologic approaches to solidify our understanding of HIV in America. With the rising opioid epidemic in the United States, resulting in localized HIV outbreaks, the impact of OUD on HIV is increasingly relevant. Dr. Nora Volkow, Director of the National Institute of Drug Abuse, will give a special lecture on the subject. Speakers will discuss strategies specific to addressing HIV in patients who inject drugs (PWID), incorporating treatment of OUD into infectious disease practice, and the value of harm reduction strategies, such as supervised injection facilities, in improving outcomes in PWID.
IHV2019 Thematic Sessions
Day 1, October 3 - Zero Transmission
Responses to HIV/AIDS Epidemic
HIV/AIDS Prevention Strategies
Day 2, October 4 - Opioid Intersection
Epidemiology of HIV-Opioid Intersection
Closing the Gap
A copy of our speaker schedule is available on our website. Check back often for updates.
Junior investigators are invited to submit research abstracts for poster presentation. Please share this opportunity with your faculty and colleagues.
A special mini-symposium will be held late afternoon on October 4th and will honor this years IHV Lifetime Achievement Awardees Warner Green, MD, PhD, Director, Gladstone Center for HIV Cure Research (Lifetime Achievement Award for Scientific Contributions), and The Honorable Parris Glendening and The Honorable Kathleen Kennedy Townsend (Lifetime Achievement Award for Public Service). The mini-symposium will be followed by a Gala Reception at 6:00 pm followed by the Lifetime Achievement Award Dinner at 6:45 pm (tickets available for purchase).
We look forward to welcoming you to Baltimore this October as we continue our annual tradition of excellent science and provocative discussion.
IHV2019 Meeting Website
Have an issue with this listing? Report it here.